Related Experiment Video
Updated: Jul 12, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
[Can we sort out from the jumble about oral contraceptives and skin cancers?]
G E Piérard1, C Piérard-Franchimont, P Quatresooz
1CHU du Sart Tilman, Liège. gerald.pierard@ulg.ac.be
Abstract:
Skin contains various hormonal receptors, particularly those for estrogens, progesterone and androgens. Steroid hormones of oral contraceptives affect the skin, in particular the control of the cell cycle, DNA replication, apoptosis and other cellular functions. Some estrogen-responsive pathways have the potential to promote tumor development. The question of whether oral contraceptives increase the risk for the development of skin cancer, particularly melanoma, remains an area of concern. There is some evidence that steroid hormones present in oral contraceptives do not significantly increase the risk of developing skin cancer when estrogen exposure is not excessive.
Insights
Oral contraceptives contain steroid hormones that affect skin cell functions. Current evidence suggests they do not significantly increase skin cancer risk, especially melanoma, if estrogen exposure is moderate.
Area of Science:
- Dermatology and endocrinology research.
- Investigating hormonal influences on skin biology.
Context:
- Skin possesses receptors for steroid hormones like estrogens, progesterone, and androgens.
- Oral contraceptives (OCs) contain synthetic steroid hormones impacting skin cellular processes.
- Hormonal pathways, particularly estrogen-responsive ones, are implicated in tumor development.
Purpose:
- To evaluate the association between oral contraceptive use and the risk of developing skin cancer, with a focus on melanoma.
- To determine if hormonal changes induced by OCs influence skin cancer development.
Summary:
- Steroid hormones in oral contraceptives influence skin cell cycle control, DNA replication, and apoptosis.
- While some estrogen pathways can promote tumor growth, evidence suggests OCs may not substantially elevate skin cancer risk.
- This risk appears mitigated when estrogen exposure from OCs is not excessive.
Impact:
- Provides insights into the dermatological safety of oral contraceptives.
- Informs clinical recommendations regarding OC use and skin cancer surveillance.
- Highlights the need for further research on hormone-skin interactions and cancer risk.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Acne Infection
Cancer Prevention
Some...
Cancer Prevention
Some...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...